As the MAPK cascade integrates signals received from the cell surface, the pathway is subject to complex regulatory and feedback mechanisms which may contribute to the reduction observed in ERK1/2 from CFS/ME patients [46, 53]. This evidence concerns the gene MAPK3 and myalgic encephalomeyelitis/chronic fatigue syndrome.